Mark Jason Heath Ellison - Jan 5, 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Chief Development Officer
Signature
/s/ Mark Jason Heath Ellison
Stock symbol
OPNT
Transactions as of
Jan 5, 2023
Transactions value $
-$36,481
Form type
4
Date filed
1/5/2023, 04:07 PM
Previous filing
Jun 29, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale -$36.5K -1.81K -8.35% $20.20 19.8K Jan 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.